Evidence map›Paper›PMID 31357997›Full record

ArticleMalaria journal2019

Community-based intermittent mass testing and treatment for malaria in an area of high transmission intensity, western Kenya: development of study site infrastructure and lessons learned.

Norbert Awino Odero, Aaron M Samuels, Wycliffe Odongo, Bernard Abong'o, John Gimnig, Kephas Otieno, Christopher Odero, David Obor, Maurice Ombok, Vincent Were and 7 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 2 countries.

Norbert Awino OderoKenya Medical Research Institute (KEMRI), Centre for Global Health Research, Kisumu, Kenya. norbodero@gmail.com.
Aaron M SamuelsCenters for Disease Control and Prevention (CDC), Atlanta, GA, USA.
Wycliffe OdongoKenya Medical Research Institute (KEMRI), Centre for Global Health Research, Kisumu, Kenya.
Bernard Abong'oKenya Medical Research Institute (KEMRI), Centre for Global Health Research, Kisumu, Kenya.
John GimnigCenters for Disease Control and Prevention (CDC), Atlanta, GA, USA.
Kephas OtienoKenya Medical Research Institute (KEMRI), Centre for Global Health Research, Kisumu, Kenya.
Christopher OderoKenya Medical Research Institute (KEMRI), Centre for Global Health Research, Kisumu, Kenya.
David OborKenya Medical Research Institute (KEMRI), Centre for Global Health Research, Kisumu, Kenya.
Maurice OmbokKenya Medical Research Institute (KEMRI), Centre for Global Health Research, Kisumu, Kenya.
Vincent WereKenya Medical Research Institute (KEMRI), Centre for Global Health Research, Kisumu, Kenya.
Tony SangKenya Medical Research Institute (KEMRI), Centre for Global Health Research, Kisumu, Kenya.
Mary J HamelCenters for Disease Control and Prevention (CDC), Atlanta, GA, USA.
S Patrick KachurCenters for Disease Control and Prevention (CDC), Atlanta, GA, USA.
Laurence SlutskerCenters for Disease Control and Prevention (CDC), Atlanta, GA, USA.
Kim A LindbladeCenters for Disease Control and Prevention (CDC), Atlanta, GA, USA.
Simon KariukiKenya Medical Research Institute (KEMRI), Centre for Global Health Research, Kisumu, Kenya.
Meghna DesaiCenters for Disease Control and Prevention (CDC), Atlanta, GA, USA.
Kenya Medical Research Institute · KECenters for Disease Control and Prevention · US

Funding

CDC HHS 5U01GH000048CGH CDC HHS U01 GH000048United States Agency for International Development GHN-T-00-06-00001-00
6 · The paper itself

Abstract

backgroundMalaria transmission is high in western Kenya and the asymptomatic infected population plays a significant role in driving the transmission. Mathematical modelling and simulation programs suggest that interventions targeting asymptomatic infections through mass testing and treatment (MTaT) or mass drug administration (MDA) have the potential to reduce malaria transmission when combined with existing interventions.

objectiveThis paper describes the study site, capacity development efforts required, and lessons learned for implementing a multi-year community-based cluster-randomized controlled trial to evaluate the impact of MTaT for malaria transmission reduction in an area of high transmission in western Kenya.

methodsThe study partnered with Kenya's Ministry of Health (MOH) and other organizations on community sensitization and engagement to mobilize, train and deploy community health volunteers (CHVs) to deliver MTaT in the community. Within the health facilities, the study availed staff, medical and laboratory supplies and strengthened health information management system to monitor progress and evaluate impact of intervention.

resultsMore than 80 Kenya MOH CHVs, 13 clinical officers, field workers, data and logistical staff were trained to carry out MTaT three times a year for 2 years in a population of approximately 90,000 individuals. A supply chain management was adapted to meet daily demands for large volumes of commodities despite the limitation of few MOH facilities having ideal storage conditions. Modern technology was adapted more to meet the needs of the high daily volume of collected data.

conclusionsIn resource-constrained settings, large interventions require capacity building and logistical planning. This study found that investing in relationships with the communities, local governments, and other partners, and identifying and equipping the appropriate staff with the skills and technology to perform tasks are important factors for success in delivering an intervention like MTaT.

Indexed as

AntimalarialsCommunity Health WorkersCommunity ParticipationHumansKenyaMalariaMass Drug AdministrationMass ScreeningVolunteersAntimalarialsEliminationInfrastructureKenyaMalariaMTaT

Identifiers

PMID31357997
PMCPMC6664589
OpenAlexW2964691276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.